Exabis Library
Welcome to the e-CCO Library!
DOP23: Decrements in quality of life associated with symptoms of Inflammatory Bowel Disease: results from the UK IBD-BOOST survey
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP23: Long-term health consequences of COVID-19 in patients with Inflammatory Bowel Diseases – A Danish prospective population-based cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP23: Myenteric plexitis and post-operative recurrence in Crohn’s disease: the role of enteric glial cells and ICAM-1
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP23: Single-cell RNA sequencing identifies an important role for class I histone-deacetylase enzymes in intestinal myofibroblasts from patients with Crohn’s Disease strictures
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP24 Patient-reported health-related quality-of-life outcomes with vedolizumab vs. adalimumab treatment of ulcerative colitis: Results of the VARSITY trial
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP24: Crohn’s Disease fistula show skewed lymphoid/myeloid balance, altered myeloid cell profiles and high TNF-α expression
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP24: Early life exposures and risk for inflammatory bowel disease: a nested case-control study in Quebec, Canada
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP24: Intestinal acidification sensed by pH-sensing receptor GPR4 contributes to fibrogenesis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP24: Japan prospective multicenter study for optimization of COVID-19 vaccinations based on the immune response and safety profile in Inflammatory Bowel Disease patients: Interim analyses of the J-COMBAT trial
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP25 Medication use and comorbidities among elderly when compared with younger patients with inflammatory bowel disease in the TARGET-IBD cohort
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP25: Association of Enterobacteriaceae with Crohn’s Disease subtypes during remission
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP25: Clinical outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP25: Contraceptive method use according to Inflammatory Bowel Disease status among young women in the United States
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP25: Unravelling vedolizumab mechanism of action in ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP26 Real-life dosing patterns and concomitant drug use among ustekinumab-treated patients with Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP26: Biological therapy increases NCR+ ILC3 levels in IBD patients
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP26: Burden of perianal disease and perianal surgery in Crohn's disease over different therapeutic eras – a population-based study from western Hungary between 1977–2020, data from the Veszprem county cohort
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP26: COVID-19 vaccine effectiveness in Inflammatory Bowel Disease patients on tumor-necrosis factor inhibitors: Real world data from a mass-vaccination campaign
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP26: The relationship between vedolizumab therapeutic drug monitoring, biomarkers of inflammation, and clinical outcomes in Inflammatory Bowel Disease in the real-world setting
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP27 Transanal minimally invasive surgery (TAMIS): A novel approach for treatment of pouch failure
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM